We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Dose Reference Levels Set for Common CT Exams

By HospiMedica International staff writers
Posted on 28 Feb 2017
Researchers have laid down new Diagnostic Reference Levels (DRL) for the 10 most common head, neck, and body Computed Tomography (CT) exams to prevent unnecessary radiation exposure, and reduce overall radiation dose for patients.

The DRLs and Achievable Dose (AD) guidelines will enable healthcare facilities to optimize and personalize the exam protocols and radiation dose a patient receives, as well as the range of doses used in the facility.

The researchers from the University of Washington School of Medicine used data from the American College of Radiology (ACR) CT Dose Index Registry, the largest CT dose index registry in the world, for the two-year study. More...
The study was published online in the February 2017 issue of the journal Radiology. Previous DLRs provided only one value for a standard average-sized patient while the new DRLs are based on patient size. Healthcare facilities can now use these DRLs to compare the radiation doses they use with US national benchmarks, and optimize their CT protocols accordingly.

Kalpana M. Kanal, PhD, medical physicist and professor at UW Medicine Department of Radiology, said, “This extensive participation and totally automated complete capture of all patient examinations enabled the development of robust, clinically based national DRLs and ADs. Both ADs and DRLs are provided to encourage facilities to optimize dose to a lower level than that indicated by the DRL. Image quality must be taken into consideration when using DRLs and ADs to evaluate CT protocols on each scanner to determine if protocols are optimized. DRLs and ADs are not intended to be used for comparisons with dose indexes for individual patients. Implementation of DRLs and ADs is most effective if the facility has a system to automatically monitor patient dose indexes so that aggregate results may be evaluated.”


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Gold Member
Electrode Solution and Skin Prep
Signaspray
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.